ONCY

ONCOLYTICS BIOTECH INC ONCY

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-9.44M

Quarter to Jun 30

Free cash flow

$-8.14M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$3.75M total
MARSHALL WACE, LLP
$708.1K-13.3%
XTX Topco Ltd
$247.8KNew
SEEDS INVESTOR LLC
$245.4KNew
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
$181.3KNew
Connective Capital Management, LLC
$176.4KNew
GOLDMAN SACHS GROUP INC
$161.4KNew
TOCQUEVILLE ASSET MANAGEMENT L.P.
$139.6KNew
Everhart Financial Group, Inc.
$133.8KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$127.4KNew
PFG Investments, LLC
$121.9KNew
HRT FINANCIAL LP
$119.0KNew
Invesco Ltd.
$96.1KNew
DOLIVER ADVISORS, LP
$95.0KNew
LPL Financial LLC
$76.3KNew
FRANKLIN RESOURCES INC
$75.8KNew
CIBC WORLD MARKET INC.
$65.8KNew
GEODE CAPITAL MANAGEMENT, LLC
$63.6KNew
RENAISSANCE TECHNOLOGIES LLC
$58.9KNew
ROYAL BANK OF CANADA
$55.0KNew
FIFTH THIRD BANCORP
$43.2KNew
HEADINVEST, LLC
$42.5KNew
Badgley Phelps Wealth Managers, LLC
$38.0KNew
Clearstead Advisors, LLC
$37.0KNew
Federation des caisses Desjardins du Quebec
$34.7KNew
RAYMOND JAMES FINANCIAL INC
$34.3KNew
See all 76 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ONCY

Earnings Per Share

13fpro.ai/company/ONCY

Loading ratio trend…

ONCY key financials by period

Reported revenue, net income and operating margin by fiscal year, from ONCOLYTICS BIOTECH INC's annual filings on SEC EDGAR.

ONCOLYTICS BIOTECH INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2017$6.2M——
Source: ONCY filings on SEC EDGAR →

ONCY insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About ONCOLYTICS BIOTECH INC (ONCY): stock profile, AI score and financials

ONCOLYTICS BIOTECH INC (ONCY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ONCY is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), ONCOLYTICS BIOTECH INC reports net income of $-9.4M, free cash flow of $-8.1M. Top institutional holders of ONCY by reported 13-F value include MARSHALL WACE, LLP, XTX Topco Ltd, SEEDS INVESTOR, based on the most recent SEC filings. ONCY trades on the Nasdaq exchange and files with the SEC under CIK 1129928. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ONCY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ONCOLYTICS BIOTECH INC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1129928 →